Seed Investment Opportunity for Direct Equity 

​

 OphthoSmart as an eyecare device is targeted to replace devices with a total annual Market size of $US 1.25 Billion.

 

i-EXM(glaucoma) the artificial intelligence deep learning based module offered as software as a service (SAAS) will be ancillary tool for improving precision of Goldmann Applanation Tonometry (GAT) for measurement of intra ocular pressure (IOP) in the $US 150 million annual market occupied by applanation tonometry in which GAT is the major contributor.   

​

 We have a consolidated, well organized, lean business model. 

 

Should you be interested in investing with us please feel free to drop an email at :

info@vlenzor.com